Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14567473rdf:typepubmed:Citationlld:pubmed
pubmed-article:14567473lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:14567473lifeskim:mentionsumls-concept:C0007776lld:lifeskim
pubmed-article:14567473lifeskim:mentionsumls-concept:C0001128lld:lifeskim
pubmed-article:14567473lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:14567473lifeskim:mentionsumls-concept:C0549193lld:lifeskim
pubmed-article:14567473pubmed:issue3lld:pubmed
pubmed-article:14567473pubmed:dateCreated2003-10-21lld:pubmed
pubmed-article:14567473pubmed:abstractTextL-2-Hydroxyglutaric acid (LGA) accumulates and is the biochemical hallmark of the neurometabolic disorder L-2-hydroxyglutaric aciduria (LHGA). Although this disease is predominantly characterized by severe neurological findings and pronounced cerebral atrophy, the pathomechanisms of brain injury are virtually unknown. In the present study, we investigated the effect of LGA (0.1-1 mM) on various parameters of the glutamatergic system, namely the basal and potassium-induced release of L-[3H]glutamate by synaptosomal preparations, Na(+)-dependent L-[3H]glutamate uptake by synaptosomal preparations and Na(+)-independent L-[3H]glutamate uptake by synaptic vesicles, as well as of L-[3H]glutamate binding to synaptic plasma membranes from cerebral cortex of male adult Wistar rats. We observed that LGA significantly increased L-[3H]glutamate uptake into synaptosomes and synaptic vesicles, without altering synaptosomal glutamate release and glutamate binding to synaptic plasma membranes. Although more comprehensive studies are necessary to evaluate the exact role of LGA on neurotransmission, our findings do not support a direct excitotoxic action for LGA. Therefore, other abnormalities should be searched for to explain neurodegeneration of LHGA.lld:pubmed
pubmed-article:14567473pubmed:languageenglld:pubmed
pubmed-article:14567473pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14567473pubmed:citationSubsetIMlld:pubmed
pubmed-article:14567473pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14567473pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14567473pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14567473pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14567473pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14567473pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14567473pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14567473pubmed:statusMEDLINElld:pubmed
pubmed-article:14567473pubmed:monthSeplld:pubmed
pubmed-article:14567473pubmed:issn0885-7490lld:pubmed
pubmed-article:14567473pubmed:authorpubmed-author:SouzaDiogo...lld:pubmed
pubmed-article:14567473pubmed:authorpubmed-author:WannmacherCló...lld:pubmed
pubmed-article:14567473pubmed:authorpubmed-author:WajnerMoacirMlld:pubmed
pubmed-article:14567473pubmed:authorpubmed-author:RottaLiane...lld:pubmed
pubmed-article:14567473pubmed:authorpubmed-author:PorciúnculaLi...lld:pubmed
pubmed-article:14567473pubmed:authorpubmed-author:WyseAngela...lld:pubmed
pubmed-article:14567473pubmed:authorpubmed-author:BrusqueAna...lld:pubmed
pubmed-article:14567473pubmed:authorpubmed-author:FrizzoMarcos...lld:pubmed
pubmed-article:14567473pubmed:authorpubmed-author:Dutra...lld:pubmed
pubmed-article:14567473pubmed:authorpubmed-author:JunqueiraDébo...lld:pubmed
pubmed-article:14567473pubmed:authorpubmed-author:RibeiroCéar...lld:pubmed
pubmed-article:14567473pubmed:issnTypePrintlld:pubmed
pubmed-article:14567473pubmed:volume18lld:pubmed
pubmed-article:14567473pubmed:ownerNLMlld:pubmed
pubmed-article:14567473pubmed:authorsCompleteYlld:pubmed
pubmed-article:14567473pubmed:pagination233-43lld:pubmed
pubmed-article:14567473pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:14567473pubmed:meshHeadingpubmed-meshheading:14567473...lld:pubmed
pubmed-article:14567473pubmed:meshHeadingpubmed-meshheading:14567473...lld:pubmed
pubmed-article:14567473pubmed:meshHeadingpubmed-meshheading:14567473...lld:pubmed
pubmed-article:14567473pubmed:meshHeadingpubmed-meshheading:14567473...lld:pubmed
pubmed-article:14567473pubmed:meshHeadingpubmed-meshheading:14567473...lld:pubmed
pubmed-article:14567473pubmed:meshHeadingpubmed-meshheading:14567473...lld:pubmed
pubmed-article:14567473pubmed:meshHeadingpubmed-meshheading:14567473...lld:pubmed
pubmed-article:14567473pubmed:meshHeadingpubmed-meshheading:14567473...lld:pubmed
pubmed-article:14567473pubmed:meshHeadingpubmed-meshheading:14567473...lld:pubmed
pubmed-article:14567473pubmed:meshHeadingpubmed-meshheading:14567473...lld:pubmed
pubmed-article:14567473pubmed:meshHeadingpubmed-meshheading:14567473...lld:pubmed
pubmed-article:14567473pubmed:meshHeadingpubmed-meshheading:14567473...lld:pubmed
pubmed-article:14567473pubmed:meshHeadingpubmed-meshheading:14567473...lld:pubmed
pubmed-article:14567473pubmed:meshHeadingpubmed-meshheading:14567473...lld:pubmed
pubmed-article:14567473pubmed:year2003lld:pubmed
pubmed-article:14567473pubmed:articleTitleEffects of L-2-hydroxyglutaric acid on various parameters of the glutamatergic system in cerebral cortex of rats.lld:pubmed
pubmed-article:14567473pubmed:affiliationDepartamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.lld:pubmed
pubmed-article:14567473pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14567473pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:14567473pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14567473lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14567473lld:pubmed